Literature DB >> 26346520

Skeletal Muscle Abnormalities in Heart Failure.

Shintaro Kinugawa1, Shingo Takada, Shouji Matsushima, Koichi Okita, Hiroyuki Tsutsui.   

Abstract

Exercise capacity is lowered in patients with heart failure, which limits their daily activities and also reduces their quality of life. Furthermore, lowered exercise capacity has been well demonstrated to be closely related to the severity and prognosis of heart failure. Skeletal muscle abnormalities including abnormal energy metabolism, transition of myofibers from type I to type II, mitochondrial dysfunction, reduction in muscular strength, and muscle atrophy have been shown to play a central role in lowered exercise capacity. The skeletal muscle abnormalities can be classified into the following main types: 1) low endurance due to mitochondrial dysfunction; and 2) low muscle mass and muscle strength due to imbalance of protein synthesis and degradation. The molecular mechanisms of these skeletal muscle abnormalities have been studied mainly using animal models. The current review including our recent study will focus upon the skeletal muscle abnormalities in heart failure.

Entities:  

Mesh:

Year:  2015        PMID: 26346520     DOI: 10.1536/ihj.15-108

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  28 in total

Review 1.  Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction.

Authors:  D Walter Wray; Markus Amann; Russell S Richardson
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

2.  The role of submaximal exercise-induced skeletal muscle remodelling in heart failure with reduced ejection fraction patients.

Authors:  Anish Engineer; Shawn S Albers; Andrew S Kucey
Journal:  J Physiol       Date:  2018-12-09       Impact factor: 5.182

Review 3.  Publication trends in cachexia and sarcopenia in elderly heart failure patients.

Authors:  Jochen Springer; Stefan D Anker
Journal:  Wien Klin Wochenschr       Date:  2016-11-24       Impact factor: 1.704

4.  Curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF: Nrf2 and antioxidant mechanisms in skeletal muscle.

Authors:  Ahmed M Wafi; Juan Hong; Tara L Rudebush; Li Yu; Bryan Hackfort; Hanjun Wang; Harold D Schultz; Irving H Zucker; Lie Gao
Journal:  J Appl Physiol (1985)       Date:  2018-11-21

Review 5.  Skeletal muscle abnormalities in heart failure with preserved ejection fraction.

Authors:  Matthew Anderson Md; Clifton Forrest Parrott; Mark J Haykowsky Ph D; Peter H Brubaker Ph D; Fan Ye Md; Bharathi Upadhya Md
Journal:  Heart Fail Rev       Date:  2022-03-30       Impact factor: 4.214

6.  Neuregulin (NRG-1β) Is Pro-Myogenic and Anti-Cachectic in Respiratory Muscles of Post-Myocardial Infarcted Swine.

Authors:  Cristi L Galindo; Van Thuan Nguyen; Braxton Hill; Ethan Easterday; John H Cleator; Douglas B Sawyer
Journal:  Biology (Basel)       Date:  2022-04-29

7.  CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice.

Authors:  Jin Li; Lijun Wang; Xuejiao Hua; Haifei Tang; Rui Chen; Tingting Yang; Saumya Das; Junjie Xiao
Journal:  Mol Ther       Date:  2020-03-10       Impact factor: 11.454

Review 8.  Skeletal Muscle Myopathy in Heart Failure: the Role of Ejection Fraction.

Authors:  Mara Paneroni; Evasio Pasini; Laura Comini; Michele Vitacca; Federico Schena; Simonetta Scalvini; Massimo Venturelli
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

9.  Validity of anaerobic threshold measured in resistance exercise.

Authors:  Takayuki Masuda; Shinta Takeuchi; Yusuke Kubo; Yusuke Nishida
Journal:  J Phys Ther Sci       Date:  2022-03-14

10.  Sesamin prevents decline in exercise capacity and impairment of skeletal muscle mitochondrial function in mice with high-fat diet-induced diabetes.

Authors:  Shingo Takada; Shintaro Kinugawa; Shouji Matsushima; Daisuke Takemoto; Takaaki Furihata; Wataru Mizushima; Arata Fukushima; Takashi Yokota; Yoshiko Ono; Hiroshi Shibata; Koichi Okita; Hiroyuki Tsutsui
Journal:  Exp Physiol       Date:  2015-10-01       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.